Literature DB >> 25362852

The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner.

M Shanzer1, I Ricardo-Lax1, R Keshet1, N Reuven1, Y Shaul1.   

Abstract

The polyomavirus middle T antigen (PyMT) is an oncogene that activates the non-receptor tyrosine kinase, c-Src, and physically interacts with Taz (WWTR1). Taz is a pro-oncogenic transcription coactivator of the Tead transcription factors. The Hippo tumor suppressor pathway activates the kinase Lats, which phosphorylates Taz, leading to its nuclear exclusion and blunting Tead coactivation. We found that Taz was required for transformation by PyMT, but counter-intuitively, Taz was exclusively cytoplasmic in the presence of PyMT. We demonstrate that in the presence of PyMT, wild-type Taz was phosphorylated by Lats, in a Src-dependent manner. Consistently, a Lats refractory Taz mutant did not undergo cytoplasmic retention by PyMT. We show that Yap, the Taz paralog, and Shp2 phosphatase were nuclear excluded as well. Our findings describe a noncanonical activation of Lats, and an unprecedented Tead-independent role for Taz and Yap in viral-mediated oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25362852     DOI: 10.1038/onc.2014.347

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

Review 1.  The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals.

Authors:  Qi Zeng; Wanjin Hong
Journal:  Cancer Cell       Date:  2008-03       Impact factor: 31.743

2.  TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.

Authors:  Qun-Ying Lei; Heng Zhang; Bin Zhao; Zheng-Yu Zha; Feng Bai; Xin-Hai Pei; Shimin Zhao; Yue Xiong; Kun-Liang Guan
Journal:  Mol Cell Biol       Date:  2008-01-28       Impact factor: 4.272

Review 3.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

4.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

5.  Polyoma virus middle T antigen: meddler or mimic?

Authors:  S M Dilworth
Journal:  Trends Microbiol       Date:  1995-01       Impact factor: 17.079

6.  Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein.

Authors:  Bin Zhao; Joungmok Kim; Xin Ye; Zhi-Chun Lai; Kun-Liang Guan
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

7.  Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice.

Authors:  C T Guy; S K Muthuswamy; R D Cardiff; P Soriano; W J Muller
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

8.  Identification of regions in polyomavirus middle T and small t antigens important for association with protein phosphatase 2A.

Authors:  K S Campbell; K R Auger; B A Hemmings; T M Roberts; D C Pallas
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

Review 9.  Lessons from polyoma middle T antigen on signaling and transformation: A DNA tumor virus contribution to the war on cancer.

Authors:  Brian S Schaffhausen; Thomas M Roberts
Journal:  Virology       Date:  2008-11-20       Impact factor: 3.616

10.  Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.

Authors:  Mitsunori Ota; Hiroshi Sasaki
Journal:  Development       Date:  2008-11-12       Impact factor: 6.868

View more
  13 in total

1.  A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling.

Authors:  Deborah Denis; Cecile Rouleau; Brian S Schaffhausen
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

2.  The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.

Authors:  Matan Shanzer; Julia Adler; Inna Ricardo-Lax; Nina Reuven; Yosef Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-01       Impact factor: 11.205

Review 3.  Tyrosine phosphorylation of WW proteins.

Authors:  Nina Reuven; Matan Shanzer; Yosef Shaul
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-26

Review 4.  Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets.

Authors:  Chandra K Maharjan; Po Hien Ear; Catherine G Tran; James R Howe; Chandrikha Chandrasekharan; Dawn E Quelle
Journal:  Cancers (Basel)       Date:  2021-10-12       Impact factor: 6.639

5.  Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP.

Authors:  Cecile Rouleau; Arun T Pores Fernando; Justin H Hwang; Nathalie Faure; Tao Jiang; Elizabeth A White; Thomas M Roberts; Brian S Schaffhausen
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

6.  Biphasic Regulation of Yes-associated Protein (YAP) Cellular Localization, Phosphorylation, and Activity by G Protein-coupled Receptor Agonists in Intestinal Epithelial Cells: A NOVEL ROLE FOR PROTEIN KINASE D (PKD).

Authors:  Jia Wang; James Sinnett-Smith; Jan V Stevens; Steven H Young; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2016-07-01       Impact factor: 5.157

7.  αE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway.

Authors:  Peng Li; Mark R Silvis; Yuchi Honaker; Wen-Hui Lien; Sarah T Arron; Valeri Vasioukhin
Journal:  Genes Dev       Date:  2016-03-24       Impact factor: 11.361

8.  AICAR Antiproliferative Properties Involve the AMPK-Independent Activation of the Tumor Suppressors LATS 1 and 2.

Authors:  Chloé Philippe; Benoît Pinson; Jim Dompierre; Véronique Pantesco; Benoît Viollet; Bertrand Daignan-Fornier; Michel Moenner
Journal:  Neoplasia       Date:  2018-05-03       Impact factor: 5.715

9.  Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis.

Authors:  Sharda P Singh; Jihyun Lee; Chhanda Bose; Hongzhi Li; Yate-Ching Yuan; Ashly Hindle; Sharad S Singhal; Jonathan Kopel; Philip T Palade; Catherine Jones; Rakhshanda L Rahman; Sanjay Awasthi
Journal:  Cancers (Basel)       Date:  2021-07-02       Impact factor: 6.639

10.  p53 and p16Ink4a/p19Arf Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells.

Authors:  Stephanie Azzopardi; Sharon Pang; David S Klimstra; Yi-Chieh Nancy Du
Journal:  Neoplasia       Date:  2016-09-21       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.